Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
176
datasets available to search
ShareScore release 0.9.0
Dataset results
176 results for “abemaciclib”
Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT04272645. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Br
ClinicalTrials.gov study NCT05372640. IPD Sharing: YES. Countries: 1. Publications: 0.
Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
ClinicalTrials.gov study NCT04316169. IPD Sharing: NO. Countries: 1. Publications: 0.
Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma
ClinicalTrials.gov study NCT04220892. IPD Sharing: NO. Countries: 1. Publications: 0.
Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance
ClinicalTrials.gov study NCT04545710. IPD Sharing: NO. Countries: 1. Publications: 0.
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
ClinicalTrials.gov study NCT05524584. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multiorgan Metabolic Imaging Response Assessment of Abemaciclib
ClinicalTrials.gov study NCT03339843. IPD Sharing: NO. Countries: 2. Publications: 0.
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT05095207. IPD Sharing: YES. Countries: 1. Publications: 0.
Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6
ClinicalTrials.gov study NCT04074785. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Tucatinib + Abemaciclib + Herceptin for HER2+ MBC
ClinicalTrials.gov study NCT03846583. IPD Sharing: YES. Countries: 0. Publications: 0.
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
ClinicalTrials.gov study NCT05999968. IPD Sharing: NO. Countries: 3. Publications: 0.
NEOadjuvant Abemaciclib and GIredestrant TriaL in Patients with ER-positive, HER2-negative Early Breast Cancer
ClinicalTrials.gov study NCT06259929. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT04351230. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive
ClinicalTrials.gov study NCT07100106. IPD Sharing: YES. Countries: 5. Publications: 0.
Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors
ClinicalTrials.gov study NCT03891784. IPD Sharing: NO. Countries: 1. Publications: 0.
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT06179303. IPD Sharing: NO. Countries: 1. Publications: 0.
ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL
ClinicalTrials.gov study NCT04603183. IPD Sharing: NO. Countries: 3. Publications: 0.
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03979508. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer
ClinicalTrials.gov study NCT04071262. IPD Sharing: NO. Countries: 1. Publications: 0.
Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer
ClinicalTrials.gov study NCT04352777. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.